In Reply
Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine-based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
AlphaMed Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153345/ |